This is the current revision of this page, as edited by Cewbot(talk | contribs) at 05:29, 30 January 2024(Maintain {{WPBS}} and vital articles: 2 WikiProject templates. Create {{WPBS}}. Keep majority rating "Start" in {{WPBS}}. Remove 2 same ratings as {{WPBS}} in {{WikiProject Pharmacology}}, {{WikiProject Medicine}}.). The present address (URL) is a permanent link to this version.
Revision as of 05:29, 30 January 2024 by Cewbot(talk | contribs)(Maintain {{WPBS}} and vital articles: 2 WikiProject templates. Create {{WPBS}}. Keep majority rating "Start" in {{WPBS}}. Remove 2 same ratings as {{WPBS}} in {{WikiProject Pharmacology}}, {{WikiProject Medicine}}.)
This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
I'm guessing it has been "unofficially adopted" as the nonproprietary name (INN) stem for CETP inhibitors, like -coxib for COX 1/2 inhibitors. I can't find it in the online version of the "stem book" [[1]], so I'm guessing that it's either not been formalized by whatever body updates the INN system.. Who makes changes in INN stem naming conventions "official" anyway?